Biomarker Value of Neurofilaments and Glial Fibrillary Acidic Protein in Central Nervous System Lymphoma and Tumors
- PMID: 36514520
- PMCID: PMC9723831
- DOI: 10.29399/npa.28312
Biomarker Value of Neurofilaments and Glial Fibrillary Acidic Protein in Central Nervous System Lymphoma and Tumors
Conflict of interest statement
Conflict of Interest: The authors declared that there is no conflict of interest.
References
-
- Lah TT, Novak M, Breznik B. Brain malignancies:glioblastoma and brain metastases. Semin Cancer Biol. 2020;60:262–273. Epub 2019 Oct 22. PMID:31654711. - PubMed
-
- Wesseling P, Capper D. WHO 2016 Classification of gliomas. Neuropathol Appl Neurobiol. 2018;44(2):139–150. PMID:28815663. - PubMed
-
- Schmid D, Warnken U, Latzer P, Hoffmann DC, Roth J, Kutschmann S, et al. Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies. J Neurochem. 2021;158(2):522–538. Epub 2021 Apr 9. PMID:33735443. - PubMed
-
- Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, et al. Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol. 2018;14(10):577–589. PMID:30171200. - PubMed
-
- Oeckl P, Jardel C, Salachas F, Lamari F, Andersen PM, Bowser R, et al. Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17((5-6)):404–13. Epub 2016 Apr 11. PMID:27415180. - PubMed
Publication types
LinkOut - more resources
Full Text Sources